According to EQL Pharma AB latest financial reports the cash on hand of 7JK is $4.35M, an increase of 7.83% to 2022. At the end of 2022 company had $4.03M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $4.35M | 7.83% |
2022 | $4.03M | 55.01% |
2021 | $2.60M | 157.80% |
2020 | $1.01M | -52.47% |
2019 | $2.12M | - |